- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03998605
Protect Yourself: Abuse Prevention for People With Intellectual Disabilities (AP4ID)
February 13, 2023 updated by: Double S Instructonal Systems
The purpose of this study is to help individuals and their caregivers develop a plan on how to recognize, deal with and respond to abusive situations.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
The goal of this project is to address the current deficiencies by creating a program that will guide individuals who have intellectual disabilities and a Learning Partner (LP - care provider, relative, group home staff) in developing a comprehensive Individual Response Plan (IRP) that can be used before, during, and after an abusive event.
Behavioral skills training and behavioral relaxation training -- two instructional approaches with evidence for effectiveness in this population -- will be included to address the unique learning needs of people who have intellectual disabilities and to maximize opportunities for skill-based learning.
Video and workbook activities will train the LP to effectively implement the abuse prevention and response strategies, thus increasing the potential for generalization in the natural environment and long-term maintenance of skills.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Martin R Sheehan, Ph.D.
- Phone Number: 641-603-0304
- Email: DocMartin817@yahoo.com
Study Contact Backup
- Name: Laura Jones, Ph.D
- Phone Number: 541-603-0304
- Email: jonesl@linnbenton.edu
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97405
- Double S Instructional Systems
-
Contact:
- Laura Jones, Ph.D
- Phone Number: 541-603-0304
- Email: jonesl@linnbenton.edu
-
Contact:
- Martin Sheehan, Ph.D
- Phone Number: 541-603-0304
- Email: DocMartin817@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- has moderate to mild mental retardation based on IQ scores ranging from 40-70
- is over 18 years old. --the participant must be able to do three of the following four skills (1) complete a simple worksheet with assistance, (2) go on simple errands alone, (3) recognize 10 or more words by site, (4) read a digital clock.
Exclusion Criteria:
- individuals who have experienced traumatic abuse and experiences symptoms suggestive of trauma, such as flashbacks, nightmares, and chronic anxiety and/or depression that is resistant to standard pharmacological and psychotherapy/behavior interventions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Abuse Prevention Program Condition
The abuse prevention program will address: (1) BEFORE -- (a) Learning about problem of abuse and what abuse is; (b) Knowing about types of abuse, who the abusers are and where abuse happens; (c) Planning ahead and identifying safe people; (2) DURING -- (a) Rejecting abuse by saying "no;" (b) Getting away if possible/staying safe and paying attention, (c) Staying calm and getting home; and (3) AFTER -- (a) Telling your safe person, (b) Knowing what to do and what not to do, and (c) Reporting the abuse and getting help to cope with the event.
|
The abuse prevention program will be comprised of nine shared learning modules for the individual with Intellectual Disabilities (ID) and a care provider.
Each shared module will contain an action step in the Individual Response Plan and will include video, guided practice and workbook activities to equip persons with ID with a range of judgment, decision-making skills and the efficacy needed for identifying, rejecting, and reporting abuse.
|
Active Comparator: Control condition
During the study the control group will receive 12 activity sheets from the ESCAPE-NOW curriculum.
Six activity sheets will be given at the initial meeting and half way through the study the remaining activity sheets will be mailed to the dyads.
We chose these activity sheets because they provide abuse information that was designed for individuals with ID.
|
The control group will receive worksheets from the ESCAPE-NOW curriculum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abuse Protection Concept Questionnaire
Time Frame: Pre, post (9 weeks), and 2 month follow-up
|
This questionnaire assesses change in knowledge and attitude about various types of abuse in individuals with Intellectual Disability (ID).
The questionnaire includes three sub scales.
The first sub-scale is comprised of five open ended questions.
Score answers range from 0 to 3 with a total score of 15.
Higher scores reflect higher knowledge.
The second sub-scale presents structured questions about the five types of abuse.
The total possible score for the first part of the second sub-scale is 5 -- with higher score reflecting greater knowledge.
Participants are then shown five pictures depicting types of abuse.
Each correct response was awarded a point for a total of five.
The total possible score for sub-sale 2 is 10.
Sub-scale 3 is a 20 item forced choice -- yes (1) , no (0), don't know (0) - that assesses knowledge and attitudes.
with a total possible sub-score of 20 -- higher score equals higher knowledge.
|
Pre, post (9 weeks), and 2 month follow-up
|
Abuse Protection Decision Making and Task Analysis Check Sheet
Time Frame: Pre, post (9 weeks), and 2 month follow-up
|
This checklist assesses change in knowledge required by people with ID to recognize and report abuse.
It consists of five vignettes of abusive situations and two non-abusive.
Each vignette has a a possible score of 10.
The total possible score for all seven vignettes is 70 with higher scores reflecting greater knowledge.
|
Pre, post (9 weeks), and 2 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glascow Social Self-Efficacy Scale
Time Frame: Pre, post (9 weeks), and 2 month follow-up
|
Change in social self-efficacy in people with moderate to mild intellectual disabilities as measured by the 17-item self-efficacy scale.
A three point response format is used to answer each question: not at all, a little bit, or a lot.
Responses are scored 0,1, and 2 respectively giving a range of 0-34.
Higher values represent better outcomes.
|
Pre, post (9 weeks), and 2 month follow-up
|
Test of Interpersonal Competence and Personal Vulnerability
Time Frame: Pre, post (9 weeks), and 2 month follow-up
|
Change in the 20-item multiple-choice interpersonal competence and vulnerability of individuals with ID.
Each question has three answers with only one best answer for each question.Scoring is from 0 to 1 with 1 being the best answer.
Scores range from 0 to 20 with higher scores showing improvement in interpersonal competence and personal vulnerability.
|
Pre, post (9 weeks), and 2 month follow-up
|
Social Vulnerability Questionnaire
Time Frame: Pre, post (9 weeks), and 2 month follow-up
|
Change in social vulnerability in individuals with ID as measured by 45 items that assess social vulnerability.
Care provider rates individual with ID on a 4-point Likert scale (1=not true or never to 4= very true or always).
Scores range from 45 to 180.
Lower scores reflect improvements in social vulnerability.
|
Pre, post (9 weeks), and 2 month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adults with ID Consumer Satisfaction
Time Frame: Post (9 weeks)
|
This consumer satisfaction scale for people with ID consists of 15 items and 1 open-ended question that assesses relevance and clarity of materials and program use barriers.
The 15 items are rated on a three point scale -1= not at all; 2= somewhat; and 3= a lot.
The total possible score was 45.
Higher scores reflect greater satisfaction with the program.
|
Post (9 weeks)
|
Learning Partner Consumer Satisfaction
Time Frame: Post (9 weeks)
|
This consumer satisfaction scale for the care giver (Learning Partner) consists of 31 items, and 1 open-ended question to assess usability and effectiveness of materials.
The five point scale ranged from 1= strongly agree to 5= strongly disagree.
The total possible score was 155 with lower scores reflecting greater satisfaction with the program.
|
Post (9 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 4, 2022
Primary Completion (Anticipated)
November 30, 2022
Study Completion (Anticipated)
December 31, 2022
Study Registration Dates
First Submitted
June 22, 2019
First Submitted That Met QC Criteria
June 24, 2019
First Posted (Actual)
June 26, 2019
Study Record Updates
Last Update Posted (Actual)
February 15, 2023
Last Update Submitted That Met QC Criteria
February 13, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AbusePhaseII
- R44HD079119-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual participant data for all primary and secondary outcome measures will be made available.
IPD Sharing Time Frame
Data will be available within 6 months of study completion.
IPD Sharing Access Criteria
Data access requests will be reviewed by an external independent reviewer.
Requestors will be required to sign a data access agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abuse Prevention
-
Johns Hopkins Bloomberg School of Public HealthUniversity of Massachusetts, Lowell; Barry UniversityRecruitingChild Sexual Abuse | Program Evaluation | Perpetration of Child Sexual Abuse | Prevention InterventionUnited States
-
Norwegian School of Sport SciencesUniversity of Toronto; University of Agder; UiT The Arctic University of Norway; The Norwegian Women´s Public Health Association and other collaboratorsCompletedPsychological Distress | Prevention | Sexual Abuse | Sexual HarassmentNorway
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)CompletedDrug Abuse PreventionUnited States
-
University of PittsburghNational Institute on Drug Abuse (NIDA)CompletedPrevention of Drug Abuse RiskUnited States
-
New York UniversityNational Institute on Drug Abuse (NIDA); University of TartuUnknownSubstance Abuse, Intravenous | Prevention and ControlUnited States, Estonia
-
American Institutes for ResearchCompletedSmoking Tobacco | Prevention of Drug Abuse and Dependency | Alcohol Abuse and Dependency | High Risk Sex Behavior | School FailureUnited States
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)RecruitingHIV | Primary Prevention | Women's Health | Implementation Science | Intravenous Substance Abuse | Organization and AdministrationUnited States
-
University of California, Los AngelesUniversity of Miami; Brown University; The Fenway InstituteActive, not recruitingHIV Prevention | Substance Abuse | Stimulant AbuseUnited States
-
University of Rhode IslandCompletedPrevention Harmful EffectsUnited States
-
University of MiamiCompletedSubstance Use | Sexual Behavior | Prevention | Family FunctionUnited States
Clinical Trials on Abuse Prevention Program
-
Koç UniversityCompleted
-
Manipal college of NursingManipal UniversityRecruitingSubstance AbuseNepal
-
Boston Medical CenterCenters for Disease Control and PreventionCompletedChild AbuseUnited States
-
University of UtahCompleted
-
Federal University of Minas GeraisCompletedMenopause | Sexual AbstinenceBrazil
-
Montana State UniversityCompletedDiabetes Mellitus, Type 2United States
-
Baylor Research InstituteUniversity of North Texas Health Science CenterCompletedObesity | Pre-diabetesUnited States
-
The University of Texas Medical Branch, GalvestonWithdrawnHypertension | Prediabetic State | Overweight or Obesity | Gestational Weight Gain
-
Assistance Publique - Hôpitaux de ParisCompletedSuicide, AttemptedFrance
-
Samara State Medical UniversityActive, not recruitingCarious and Non-carious Lesions of the TeethRussian Federation